Skip to main content
. Author manuscript; available in PMC: 2021 Jul 2.
Published in final edited form as: Patient. 2020 Oct;13(5):557–566. doi: 10.1007/s40271-020-00423-w

Table 2:

Survivor Rankings of the Eleven Criteria in the Multi-Criteria Decision Analysis Item for Chemotherapy Preference (N=694)

Criteria Median (IQR)
Fighting my Cancer 2 (1, 4)
A Chance to Reduce my Risk for the Cancer Coming Back 2 (1, 4)
Long Term Effects of Chemotherapy 3 (2, 6)
Probability of Fatigue 6 (4, 7)
Probability of Nausea/Vomiting 6 (4, 8)
Inability to Maintain Lifestyle 6 (4, 8)
Caring for Family 7 (4, 9)
Probability of Hair Loss 8 (5, 10)
Inability to Work 8 (5, 10)
Trips to Hospital/Clinic for Treatment 9 (7, 10)
Out of Pocket Cost for Chemotherapy 9 (7, 11)

IQR = Interquartile Range

To calculate the differenced MCDA score, each respondent’s rankings from 1 to 11 were converted into rank order centroid (ROC) weights. For each criteria, a utility weight was determined for both the chemotherapy and the no chemotherapy treatment options. Each respondent’s ROC weights were multiplied by the criteria’s chemotherapy utility weight and added together to form a chemotherapy score. The ROC weights were also multiplied by each criteria’s no chemotherapy utility weight to form a no chemotherapy score. The differenced MCDA score was calculated as the chemotherapy score minus the no chemotherapy score, rescaled from 0 to 10.